Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Biotech Firm Celsion Corp (CLSN) Leads VE Small Cap Newsletter

|Includes:Celsion Corporation (CLSN)

VALUATION WARNING: Our models find that overvaluation is at levels typically seen when market pullbacks occur. Overvalued stocks assigned a valuation now make up almost 85% of our universe and almost 53% of the stocks assigned a valuation are calculated to be overvalued by 20% or more. ALL sectors are calculated to be overvalued--15 of them by double digits.

Healthy Performance

--Celsion Corp (NASDAQ:CLSN) Leads Small Cap Newsletter

Celsion is dedicated to the development and commercialization of oncology drugs including tumor-targeting treatments using focused heat energy in combination with heat activated drug delivery systems. Celsion has research, license or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, North Shore Long Island Jewish Health System.

Despite the latest market gyrations, we still see decent performance from some of our long-focused newsletters. Our VE Small Cap Stock Newsletter. Right now the top performer for our small caps is Celsion Corp. The stock is up more than 10% for the past month.

ValuEngine continues its BUY recommendation on CELSION CORP for 2014-01-14. Based on the information we have gathered and our resulting research, we feel that CELSION CORP has the probability to OUTPERFORM average market performance for the next year. The company exhibits ATTRACTIVE Earnings Growth Rate and Book Market Ratio.

As a bonus to our Daily Bulletin readers,
we are offering a FREE DOWNLOAD of one of our Stock Reports

Read our Complete Detailed Valuation Report on Celsion Corp. HERE.

Below is today's data on CLSN:


 






ValuEngine Forecast
  Target
Price*
Expected
Return
1-Month 4.38 6.78%
3-Month 4.32 5.35%
6-Month 4.31 5.20%
1-Year 6.49 58.35%
2-Year 5.12 24.80%
3-Year 6.69 63.23%
Click to enlarge

 















 

 

Valuation & Rankings
Valuation 73.27% undervalued Valuation Rank 100
1-M Forecast Return 6.78% 1-M Forecast Return Rank 100
12-M Return -89.93% Momentum Rank 1
Sharpe Ratio -0.20 Sharpe Ratio Rank 38
5-Y Avg Annual Return -22.35% 5-Y Avg Annual Rtn Rank 28
Volatility 112.71% Volatility Rank 15
Expected EPS Growth 30.30% EPS Growth Rank 63
Market Cap (billions) 0.06 Size Rank 30
Trailing P/E Ratio n/a Trailing P/E Rank 5
Forward P/E Ratio n/a Forward P/E Ratio Rank n/a
PEG Ratio 0.10 PEG Ratio Rank 86
Price/Sales 142.87 Price/Sales Rank 3
Market/Book 1.91 Market/Book Rank 54
Beta 1.12 Beta Rank 50
Alpha n/a Alpha Rank n/a
Click to enlarge
ValuEngine Market Overview

 

 

 

 

 

Summary of VE Stock Universe
Stocks Undervalued 15.29%
Stocks Overvalued 84.71%
Stocks Undervalued by 20% 4.92%
Stocks Overvalued by 20% 52.91%
Click to enlarge

 

ValuEngine Sector Overview

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sector Change MTD YTD Valuation Last 12-MReturn P/E Ratio
Medical 1.19% 4.78% 4.78% 34.53% overvalued 42.92% 29.83
Computer and Technology 1.63% 2.06% 2.06% 32.21% overvalued 34.34% 31.26
Aerospace 1.19% 2.50% 2.50% 31.55% overvalued 52.55% 19.27
Multi-Sector Conglomerates 0.76% -0.95% -0.95% 30.92% overvalued 14.69% 19.70
Consumer Discretionary 0.69% 0.24% 0.24% 30.25% overvalued 41.31% 29.89
Transportation 0.96% -0.57% -0.57% 28.35% overvalued 37.27% 22.50
Auto-Tires-Trucks 1.13% 0.78% 0.78% 26.71% overvalued 40.87% 19.69
Industrial Products 0.76% 0.04% 0.04% 25.50% overvalued 33.65% 23.62
Business Services 1.06% -0.18% -0.18% 24.90% overvalued 33.85% 26.44
Retail-Wholesale 0.74% -2.49% -2.49% 22.21% overvalued 33.09% 24.06
Consumer Staples 0.81% -0.48% -0.48% 21.78% overvalued 23.06% 23.59
Finance 0.56% -0.28% -0.28% 21.03% overvalued 13.32% 17.70
Construction 0.84% 1.27% 1.27% 16.74% overvalued 28.04% 24.98
Oils-Energy 0.67% -0.91% -0.91% 12.15% overvalued 10.93% 26.62
Utilities 0.75% 1.07% 1.07% 11.69% overvalued 10.16% 20.40
Basic Materials 0.36% 0.32% 0.32% 8.01% overvalued -25.04% 21.72
Click to enlarge

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Stocks: CLSN